Your 'focus' is a liability.
We're treating stimulants like free perks. Here's the hidden cost.
⚡ The Signal
The AI arms race has a new perk: performance enhancers. In the relentless push for an edge, some VCs and founders are now stocking office pantries with nicotine pouches right next to the cold brew. This isn't about smoke breaks; it's about shipping code faster. What was once a bio-hacker's niche is becoming a line item on the startup P&L, signaling a new, unregulated frontier in workplace productivity.
🚧 The Problem
We are meticulous about tracking our digital habits, going as far as using apps that make us do squats before opening Instagram. We track our screen time, our calories, and our sleep. Yet, we have a massive blind spot when it comes to the chemical inputs we use to manage our energy and focus. We chug coffee and pop nicotine pouches with zero quantitative insight into their actual physiological cost. What was the impact of that 2 PM espresso on your deep sleep? How did that nicotine pouch affect your resting heart rate? Right now, we're flying blind, optimizing for short-term output while accumulating a long-term, invisible physiological debt.
🚀 The Solution
Enter Basal, a dopamine dashboard for the modern knowledge worker. Basal isn't another habit tracker or a wellness app that tells you to meditate more. It’s a data-first platform to help you understand the hidden physiological cost of your focus habits. By integrating with your existing health wearables (Oura, Whoop, Apple Watch), Basal connects the dots between your caffeine or nicotine intake and your core biometric data—HRV, sleep quality, recovery scores, and more. The goal isn't judgment; it's correlation. Basal's value proposition is simple: see the data, understand the trade-offs, and replace blunt instruments with sustainable alternatives that actually work for your body.
